Position in PRLD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,034,406
+$243,037 QoQ
Shares Held
302,458
+10.8% QoQ
Ownership
0.380%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. PRLD ranks #316 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in PRLD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,034,406 | 302,458 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $791,369 | 272,886 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $313,297 | 217,568 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $176,011 | 217,568 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $311,004 | 404,955 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $512,977 | 402,336 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $810,851 | 391,716 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,379,033 | 361,951 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,714,135 | 361,632 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,491,797 | 349,367 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,023,099 | 331,100 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,090,323 | 242,294 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $831,652 | 145,904 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $873,849 | 144,677 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,011,931 | 153,091 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $708,046 | 135,641 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,432,274 | 207,576 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,647,318 | 212,636 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $7,786,625 | 249,172 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $6,391,704 | 223,252 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,630,946 | 199,191 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $13,710,983 | 191,628 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||